Stephen H. Polmar

Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Amos Cohen, R Hirschhorn, Sheldon D. Horowitz et al. · Proceedings of the National Academy of Sciences · 1978 · 401 citations · Full text

Life Sciences, Biochemistry, Pediatrics +14

Enzyme Replacement Therapy for Adenosine Deaminase Deficiency and Severe Combined Immunodeficiency

Stephen H. Polmar, Robert C. Stern, Alan L. Schwartz et al. · New England Journal of Medicine · 1976 · 250 citations

Life Sciences, Hematology, Immunology +17

Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia

Judith Branger, Bernt van den Blink, Sebastiaan Weijer et al. · The Journal of Immunology · 2002 · 232 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Adenosine deaminase deficiency with late onset of recurrent infections: Response to treatment with polyethylene glycol-modified adenosine deaminase

Yael Levy, Michael S. Hershfield, Cristina Fernández‐Mejía et al. · The Journal of Pediatrics · 1988 · 214 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +6

Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome.

Thomas A. Waldmann, Stephen H. Polmar, Suellen T. Balestra et al. · PubMed · 1972 · 138 citations

Life Sciences, Immunology, Internal Medicine +17